| Literature DB >> 35289860 |
Elisabeth D Riviello1,2, Tenzin Dechen3, Ashley L O'Donoghue2,3, Michael N Cocchi2,4, Margaret M Hayes1,2, Rose L Molina2,5, Nicole H Moraco6,7, Anne Mosenthal7,8, Michael Rosenblatt7, Noa Talmor3, Daniel P Walsh2,4,9, David N Sontag2,10,11, Jennifer P Stevens1,2,3.
Abstract
Importance: Crisis standards of care (CSOC) scores designed to allocate scarce resources during the COVID-19 pandemic could exacerbate racial disparities in health care. Objective: To analyze the association of a CSOC scoring system with resource prioritization and estimated excess mortality by race, ethnicity, and residence in a socially vulnerable area. Design, Setting, and Participants: This retrospective cohort analysis included adult patients in the intensive care unit during a regional COVID-19 surge from April 13 to May 22, 2020, at 6 hospitals in a health care network in greater Boston, Massachusetts. Participants were scored by acute severity of illness using the Sequential Organ Failure Assessment score and chronic severity of illness using comorbidity and life expectancy scores, and only participants with complete scores were included. The score was ordinal, with cutoff points suggested by the Massachusetts guidelines. Exposures: Race, ethnicity, Social Vulnerability Index. Main Outcomes and Measures: The primary outcome was proportion of patients in the lowest priority score category stratified by self-reported race. Secondary outcomes were discrimination and calibration of the score overall and by race, ethnicity, and neighborhood Social Vulnerability Index. Projected excess deaths were modeled by race, using the priority scoring system and a random lottery.Entities:
Mesh:
Year: 2022 PMID: 35289860 PMCID: PMC8924715 DOI: 10.1001/jamanetworkopen.2022.1744
Source DB: PubMed Journal: JAMA Netw Open ISSN: 2574-3805
Crisis Standards of Care Priority Scoring System
| Principle | Specification | Point system | |||
|---|---|---|---|---|---|
| 1 Point | 2 Points | 3 Points | 4 Points | ||
| Save lives | Prognosis for short-term survival (SOFA score) | SOFA score <6 | SOFA score 6-9 | SOFA score 10-12 | SOFA score >12 |
| Save life-years | |||||
| Apr 13-27, 2020 | Prognosis for long-term survival of the immediate illness (medical assessment of comorbid conditions) | NA | Major comorbid conditions with substantial impact on long-term survival of immediate illness | NA | Severely life limiting conditions; death likely within 1 y |
| Apr 28 to May 22, 2020 | Prognosis for continued survival (medical assessment of underlying conditions that severely limit life expectancy) | NA | Major underlying conditions that significantly limit near-term prognosis; death likely within 5 y | NA | Severely life-limiting conditions; death likely within 1 y |
Abbreviations: NA, not applicable; SOFA, Sequential Organ Failure Assessment.
On April 28, 2020, institutions began to use an estimate of life expectancy instead of a measure of comorbidities in response to the Massachusetts revised guidelines. Attending physicians were asked to respond to the following questions: (1) “In your best clinical judgment based on the patient’s known underlying conditions that preceded this acute illness, do you think this patient is likely to survive more than 1 year? If answer is NO, then Score +4 points”; (2) “In your best clinical judgment based on the patient’s known underlying conditions that preceded this acute illness, do you think this patient is likely to survive more than 5 years? If answer is NO, then Score +2 points”; and (3) “If, in your best clinical judgment, you think the patient IS likely to survive more than 5 years, then Score 0 points.”
Patient Characteristics and Outcomes Overall and by Race
| Characteristic | Patients, No. (%) | |||||||
|---|---|---|---|---|---|---|---|---|
| Overall (N = 498) | Black (n = 79) | White (n = 298) | Asian (n = 11) | Other (n = 46) | Unknown (n = 64) | Black vs White | Black vs all others | |
| Demographic and clinical characteristics | ||||||||
| Age, median (IQR), y | 67 (56-75) | 68 (59-75) | 69 (57-76) | 62 (59-72) | 63 (52-73) | 59 (50-69) | .76 | .43 |
| Female | 191 (38.4) | 26 (32.9) | 117 (39.3) | 4 (36.4) | 15 (32.6) | 29 (45.3) | .30 | .28 |
| Male | 307 (61.6) | 53 (67.1) | 181 (60.7) | 7 (63.6) | 31 (67.4) | 35 (54.7) | ||
| COVID-19 positive | 225 (45.7) | 57 (72.2) | 94 (31.5) | 9 (81.8) | 29 (63) | 36 (56.3) | <.001 | <.001 |
| Outcomes | ||||||||
| Ventilated | 244 (49.5) | 41 (51.9) | 120 (40.3) | 7 (63.6) | 26 (56.5) | 50 (78.1) | .08 | .64 |
| Time on ventilator, median (IQR), d | 10 (4-19) | 15 (6-25) | 8 (3-16) | 10 (6-12) | 15 (7-23) | 14 (7-23) | .01 | .10 |
| LOS, median (IQR), d | ||||||||
| ICU | 6 (3-17) | 8 (3-21) | 5 (3-11) | 13 (8-18) | 22 (25-31) | 16 (8-26) | .004 | .19 |
| Hospital | 13 (7-25) | 13 (8-28) | 10 (6-19) | 18 (9-31) | 17 (9-38) | 22 (13-31) | .01 | .26 |
| Discharged home | 165 (45.3) | 19 (24.1) | 108 (36.2) | 3 (27.3) | 19 (41.3) | 16 (25) | .13 | .13 |
| In-hospital death | 119 (23.9) | 21 (26.6) | 62 (20.8) | 3 (27.3) | 14 (30.4) | 19 (29.7) | .27 | .54 |
Abbreviations: ICU, intensive care unit; LOS, length of stay.
Other includes any race indicated by the patient or surrogate that was not Black, White, or Asian.
All others includes all other races as well as patients with unknown race.
Proportion of Patients in the Lowest Priority Score Group for Overall Priority Score and Component Scores, Black vs White and Black vs All Others
| Groups | Patients, No. (%) | Patients, No. (%) | |||||
|---|---|---|---|---|---|---|---|
| Overall (n = 498) | Black (n = 79) | White (298) | Black (n = 79) | All others (n = 419) | |||
|
| |||||||
| Lowest priority group (most severe, scores 6-8) | 46 (9.2) | 12 (15.2) | 25 (8.4) | .07 | 12 (15.2) | 34 (8.1) | .046 |
| Higher priority groups (less severe, scores 1-5) | 452 (90.7) | 67 (84.8) | 273 (91.6) | 67 (84.8) | 385 (91.9) | ||
|
| |||||||
| Lowest priority SOFA group (most severe, group 4) | 33 (6.6) | 7 (8.9) | 14 (4.7) | .15 | 7 (8.9) | 26 (6.2) | .38 |
| Higher priority SOFA groups (less severe, groups 1-3) | 465 (93.4) | 72 (91.1) | 284 (95.3) | 72 (91.1) | 393 (93.8) | ||
|
| |||||||
| Lowest priority comorbidity group (most severe, score 4) | 19 (3.8) | 3 (3.8) | 14 (10.9) | .69 | 3 (8.6) | 16 (8.2) | .99 |
| Higher priority comorbidity groups (less severe, scores 0 or 2) | 211 (91.7) | 32 (91.4) | 115 (89.2) | 32 (91.4) | 179 (91.8) | ||
|
| |||||||
| Lowest priority life expectancy group (most severe, score 4) | 43 (16.0) | 9 (20.4) | 26 (15.4) | .41 | 9 (20.4) | 34 (15.2) | .38 |
| Higher priority life expectancy groups (less severe, scores 0 or 2) | 225 (84.0) | 35 (79.6) | 143 (84.6) | 35 (79.6) | 190 (84.8) | ||
Abbreviation: SOFA, Sequential Organ Failure Assessment.
The P values reflect the comparison of patients in the lowest priority grouping for the overall priority score as well as the component scores (ie, SOFA, life expectancy, comorbidity) compared with all other higher-priority score values. Overall χ2 test was used to test difference across groups. Fisher exact test was used for cell counts less than 5.
All others includes all other races as well as patients with unknown race.
On April 28, 2020, institutions began to use an estimate of life expectancy instead of a measure of comorbidities in response to the Massachusetts revised guidelines. A total of 230 patients had comorbidity scores; 268 had life expectancy scores. Column percentages for comorbidity points and life expectancy points were based on these totals.
Figure 1. In-Hospital Mortality by Priority Score
In-hospital mortality by priority score for all patients (A) and White and Black patients (B). The size of the bubble represents the total number of patients in each priority score group.
Figure 2. Comparison of Priority Score Allocation Strategy vs Random Lottery Allocation in Scenarios of Scarcity
Baseline deaths defined as how many patients in our cohort died. Excess deaths defined as how many patients lived in our cohort but were estimated to have died in each scenario if we had to ration resources. For the random lottery allocation of ventilators at cutoffs of score of 2 or lower and 5 or lower, we ran 10 000 trials in which we randomly assigned individuals to receive a ventilator (where 140 individuals did not receive a ventilator at cutoff ≤2 and 30 individuals did not receive a ventilator at cutoff ≤5, including only patients who actually received ventilation in our cohort). Other race includes any race indicated by the patient or surrogate that was not Black, White, or Asian.